| Stage | SNDK | % of rev | AXTI | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $11.0B | 100.00% | $48M | 100.00% | SNDK ×231.80 |
| Gross profit | $9.4B | 85.01% | $21M | 44.90% | SNDK +40.1pp |
| Operating income | $8.8B | 79.59% | $10M | 21.90% | SNDK +57.7pp |
| Pre-tax income | $9.3B | 84.48% | $15M | 31.80% | SNDK +52.7pp |
| Net income | $8.1B | 73.44% | $13M | 27.38% | SNDK +46.1pp |
| Stage | SNDK | AXTI | Gap · A − B |
|---|---|---|---|
| Revenue | $11.0B100.00% | $48M100.00% | SNDK ×231.80 |
| Gross profit | 85.01%$9.4B | 44.90%$21M | SNDK +40.1pp |
| Operating income | 79.59%$8.8B | 21.90%$10M | SNDK +57.7pp |
| Pre-tax income | 84.48%$9.3B | 31.80%$15M | SNDK +52.7pp |
| Net income |
| 73.44%$8.1B |
| 27.38%$13M |
| SNDK +46.1pp |
No disclosed counterparties: AXTI.
None